This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at [email protected] or call + 1 (702) 988 2320.
Title: The centers of premeltons signal the beginning and ends of genes
Title: Importance of personalized precision nutrition and functional foods in healthy aging
Title: Personalized and precision medicine as a unique healthcare model through the view of biodesign and translational armamentarium of the newest generation
Title: Evaluation of clinical effectiveness of using enzyme-linked immunosorbent assay (ELISA) tests for measuring drug levels and/or their anti-drug antibodies for the purpose of monitoring treatment response and guiding decisions about the use of tumour necrosi
Title: S-Adenosylmethionine as a precision adjunct therapy to chemotherapeutic alkylating agents in attenuating side effects and improving outcomes in various cancers
Title: Predictive, precise, personalized and prognostic medicine for NAFDL, NASH and Liver cancers in sub-saharan africa: Challenges, solutions and perspectives
Title: Update on patent eligibility in the United states: Precision medicine in the cross-hairs
Title: Aging while black: Understanding the role of faith & culture to address health disparities among African Americans across the life span
Title: Absolute quantitation of protein biomarkers to improve the accuracy of breast cancer diagnostics
Title: Pathogenicity of cancer alterations when the genotype and expected phenotype do not match: an integrated evaluation of germline and somatic genomic results
Title: Pathway-centric approaches to uncover markers of treatment response in cancer patients
Title: Keeping cancer in remission - A consensus from patients
Title: A machine learning approach to identify a circulating microRNA signature for Alzheimer disease
Title: MicroARNs are biomarkers of cardiovascular events due to Chronic Kidney Disease
Title: The Role of Metabolomics in Precision Medicine of Osteoarthritis: Where Are We Now?
Title: Functionalized Red Carbon Nanodots for Precision Cancer Chemo-Phototherapy
Title: Pain: an opioid epidemic requiring a non-opioid alternative
Title: Implementing a comprehensive precision medicine paradigm into primary care clinics
Title: Genomic variability of animal models as platforms for accelerating precision medicine: applications for lysosomal storage diseases and Parkinson’s disease
Title: Profiling the response to neoadjuvant chemoradiotherapy in Locally Advanced Rectal Cancer
Title: A Randomized Controlled Trial of Wooden Tongue Depressor Exercise Therapy versus Usual Care to Improve Mouth Opening Ability Among Head and Neck Cancer Patients
Title: Calcium-sensing Receptor Antagonist NPS-2143 Inhibits Breast Cancer Cell Proliferation, Migration and Invasion via Downregulation of p-ERK1/2, Bcl-2 and Integrin ?1 and Induces Caspase 3/7 Activation
Title: Towards quantitative perfusion MRI of the lung in COPD: The problem of short-term repeatability
Title: Normalized by platelets count serum EGF levels: A potential biomarker in non-small cell lung cancer
Title: Reagent for Monitoring Cancer Therapy Resistance in Real-time (Tumor Signal-Liquid Biopsy)
Title: Stakeholders’ interest and attitudes toward Genomic Medicine and Pharmacogenomics implementation in the United Arab Emirates: A qualitative study
Title: Oral manifestation of COVID 19 and photodynamic therapy for SARS-CoV-2 infection